» Articles » PMID: 12457719

Oropharyngeal Cancer Incidence and Mortality in Scotland: Are Rates Still Increasing?

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 2002 Nov 30
PMID 12457719
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Oropharyngeal cancer incidence and mortality rates increased in Scotland between the early seventies and late eighties. Although these increases appeared to be cohort based, they were at that time confined to younger age groups. The aim of this study was to examine recent time trends in the incidence and mortality of oropharyngeal cancers in Scotland to determine whether previous increases in incidence and mortality had continued. Oropharyngeal cancer mortality rates in Scotland between 1950 and 1998 were analysed using data from the World Health Organisation Mortality Database. Incidence trends were analysed using cancer registration data for Scotland for the period 1965-1997. Between 1989 and 1996, incidence rates for oropharyngeal cancers have risen dramatically in males (18-23.6 per 100,000) and females (7.3-8.5 per 100,000) aged 35-64 years, while age-standardised mortality rates appear to have stabilised. Although oropharyngeal cancer incidence rates continue to rise alarmingly, these increases are not necessarily translated into higher mortality rates as had been suggested by results from earlier studies.

Citing Articles

Head and neck cancer incidence is rising but the sociodemographic profile is unchanging: a population epidemiological study (2001-2020).

Smith C, McMahon A, Purkayastha M, Creaney G, Clements K, Inman G BJC Rep. 2024; 2(1):71.

PMID: 39301277 PMC: 11408244. DOI: 10.1038/s44276-024-00089-z.


Pulmonary Screening Practices of Otolaryngology-Head and Neck Surgeons Across Saudi Arabia in the Posttreatment Surveillance of Squamous Cell Carcinoma: Cross-sectional Survey Study.

Alnefaie M, Alamri A, Saeedi A, Althobaiti A, Alosaimi S, AlQurashi Y Interact J Med Res. 2022; 11(1):e24592.

PMID: 35302511 PMC: 8976246. DOI: 10.2196/24592.


Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma.

Nasman A, Holzhauser S, Kostopoulou O, Zupancic M, Ahrlund-Richter A, Du J Viruses. 2021; 13(5).

PMID: 34069114 PMC: 8156012. DOI: 10.3390/v13050910.


antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines.

Holzhauser S, Kostopoulou O, Ohmayer A, Lange B, Ramqvist T, Andonova T Oncol Lett. 2019; 18(6):6249-6260.

PMID: 31788102 PMC: 6865836. DOI: 10.3892/ol.2019.10973.


Oral cancer incidence in Shanghai ---- a temporal trend analysis from 2003 to 2012.

Fu J, Wu C, Zhang C, Gao J, Luo J, Shen S BMC Cancer. 2018; 18(1):686.

PMID: 29940896 PMC: 6019836. DOI: 10.1186/s12885-018-4582-4.